NEW METHOD OF DRUGS DELIVERY TO THE OCULAR SURFACE

Author: Safonova T.N.¹, Gladkova O.V.², Kintyukhina N.P.³

Abstract

The effectiveness of topical application of various drugs in ophthalmology is no more than 3 % due to the presence of anatomical and physiological barriers. The therapeutic effect accomplishment is possible with increasing concentration or multiplicity of drug use. The article presents the results of the development of a new type of therapeutic contact lens for the deposition of medications in order to shorten the periods of treatment and to obtain a result without repeated manipulation. The quantitative evaluation of the drug content in the lens is given. The dynamics of the release of the drug substance from the lens was determined by the method of spectrometry. Practically complete elimination of the drug from the soft contact lens (SCL) depot (both on the outer and inner surfaces of the lens) is observed on the 13–14 day. With the help of the chromatography method, the absence of drug diffusion from saturated SCL during storage in buffer solutions was proved. The design features of the lens: a depot with a drug on the external and / or internal surface of the therapeutic SCL allow for a dosed and directed effect on various structural components of the oculer surface. The presence of a transparent optical center allows maintaining high visual functions. If it is necessary to prolong therapy, it is possible to re-saturate the same SCL with a drug substance.

Key words

therapeutic soft contact lens, cyclosporin A, spectrometry, chromatography

References

Byrne M., Venkatesh S. Applications of biomimetic systems in drug delivery. Expert Opin. Drug Deliv. 2005. 2. (6). 1085–1096.

Chauhan A., Gulsen D. Dispersion of DMPC liposomes in contact lenses for ophthalmic drug delivery. Curr. Eye Res. 2005. 30. (12). 1071–1080.

Danion A., Brochu H., Martin Y., Vermette P. Fabrication and characterization of contact lenses bearing surfaceimmobilized layers of intact liposomes. J. Biomed. Mater. 2007. 82. 41-51.

Dixon P., Shafor C., Gause S., Hsu K.H., Powell K.C., Chauhan A. Therapeutic contact lenses: a patent review. Expert Opin. Ther. Pat. 2015. 25. (10). 1117–1129.

Dreifus M., Wichterle O., Lim D. Intra-cameral lenses made of hydrocolloidal acrylates. Cesk. Oftalmol. 1960. 16. 154–159. [In Czech].

Duvvuri S., Majumdar S., Mitra A. K. Drug delivery to the retina: challenges and opportunities. Expert Opin. Biol. Ther. 2003. 3. (1). 45–56.

Egorov E.A., Astakhov Yu.S., Stavitskaya T.V. Ophthalmopharmacology. Manual for the doctors. Moscow: GEOTAR-Media, 464 p. [In Russian].

Galante R., Paradiso P., Moutinho M.G., Fernandes A.I., Mata J.L., Matos A.P., Colaço R., Saramago B., Serro A.P. About the effect of eye blinking on drug release from pHEMA-based hydrogels: an in vitro study. J. Biomater Sci. Polym. Ed. 2015. 26. (4). 235–251.

Hegde R.R, Verma A., Ghosh А. Microemulsion: New insights into the ocular drug delivery. ISRN Pharm. 2013. 2013. 826798.

Hsu K., Fentzke R.C., Chauhan A. Feasibility of corneal drug delivery of cysteamine using vitamin E modified silicone-hydrogel contact lenses. Eur. J. Pharm. Biopharm. 2013. 85. 531–540.

Li C., Chauhan A. Modeling ophthalmic drug delivery by soaked contact lenses. Ind. Eng. Chem. Res. 2006. 45. 3718–3734.

Peng C., Chauhan A. Extended cyclosporine delivery by silicone-hydrogel contact lenses. J. Controlled Release. 2011. 154. 267–274.

Peng C., Kim J., Chauhan A. Extended delivery of hydrophilic drugs from silicone-hydrogel contact lenses containing vitamin E diffusion barriers. Biomaterials. 2010. 31. 4032–4047.

Safonova T.N., Gladkova O.V., Novikov I.A., Boev V.I., Kintyukhina N.P. Therapeutic silicone-hydrogel soft contact lens. Patent RF RU2612121C1; published 01.27.2016. [In Russian].

Su X., Kim B., Kim S. Layer-layer-assembled multilayer films for transcutaneous drug and vaccine delivery. ACS Nano. 2008. 3. 3719–3729.

Urtti A. Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv. Drug Deliv. Rev. 2006. 58. (11). 1131–1135.

Waite S., Gupta A., Schnell U. Drug delivery from contact lenses with a fluidic module. Patent USA US20160018671A1; published 31.03.2014.

Weiner A.L., Kabra B.P. Pulsatile peri-corneal drug delivery device. Patent USA US20160018671A1; published 25.01.2011.

White C.J., Byrne M.E. Molecularly imprinted therapeutic contact lenses. Expert Opin. Drug Deliv. 2010. 7. 765–780.

About Authors (Correspondence):

Safonova T.N. – candidate of medical sciences, leading researcher, e-mail: safotat@mail.ru

Full Text

snmzh_5-2018_safonova_i_dr_59-64.pdf

Received: 29/10/2018

Accepted: 29/10/2018